QLS31905 in Combination With CAPOX Versus Sintilimab in Combination With CAPOX as First-line Treatment in Patients With GC/GEJ

NCT07716449 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric or Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: QLS31905
DRUG: Sintilimab
DRUG: Oxaliplatin
DRUG: Capecitabine

Sponsor

Qilu Pharmaceutical Co., Ltd.